arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Caring Brands, Inc.

CABR

$1.20 ▼ -0.12 (-9.09%) at close

9 Visible periods

22 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Bullish

auto_awesome

Analytical Summary

Caring Brands, Inc. shows strong fundamentals with top-quartile Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $10.8M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC 18.6% ↘

FCF / Share $-0.05 ↘

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

9-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$420.00

↓ -43.2% —

Net Income Profit after all expenses

$-2.01M

↓ -272.8% —

FCF / Share Free cash flow per share

$-0.05

↓ -228.0% —

Long-Term Debt Long-term obligations

$58.65K

↓ -55.3% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Financial Health

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗
EPS Growth YoY (%)	-100.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-575.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	-166.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	-272.8% Weak ↑ Weak Improving Year-over-year change in net income	-272.8% Weak ↑ Weak Improving Year-over-year change in net income	-370.6% Weak Weak Year-over-year change in net income	-552.4% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	-228.0% Weak ↑ Weak Improving Year-over-year change in free cash flow	-108.4% Weak Weak Year-over-year change in free cash flow	—	-1145816.0% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗
FCF / Net Income (x)	0.23x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.27x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.26x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.18x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.39x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.45x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	0.00x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗
Return on Invested Capital (%)	18.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	67.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-137.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	13.4% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-33.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-79.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-160.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-31.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	74.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+518%)	100.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+736%)	-194.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1718%)	-39.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-427%)	-17.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-245%)	-16.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-233%)	93.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+681%)	17.0% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+41%)	—

⚖️ Is the balance sheet risky? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗
Debt to Equity (x)	—	—	0.03x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-94%)	0.05x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-90%)	—	—	—	—	—
Net Debt (USD)	$-1.82M	$-2.03M	$-2.13M	$115.14K	—	—	$-469.00K	—	—
Debt / EBITDA (x)	—	—	-0.02x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.13x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗
Revenue per Share (USD)	—	—	—	$0.00	$0.00	$0.00	—	—	—
Basic EPS, GAAP (USD)	$-0.10	$-0.27	$-0.29	$-0.08	$-0.05	$-0.04	—	$-0.03	—
Free Cash Flow per Share (USD)	$-0.05	$-0.04	—	$-0.01	$-0.02	$-0.02	—	$-0.00	—
Book Value per Share (USD)	$-0.30	$-0.23	$0.14	$0.19	$0.23	$0.26	$-0.07	$-0.07	—
Tangible Book Value per Share (USD)	$-0.30	$-0.23	$-0.03	$0.19	$0.23	$0.26	$-0.07	$-0.07	—
Basic Weighted Avg Shares (shares)	8.99M	14.45M	—	13.44M	13.34M	13.22M	—	12.78M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗
Working Capital (USD)	$1.52M	$1.79M	$2.15M	$-524.22K	—	—	$341.38K	—	—
LT Debt (USD)	—	—	$58.65K	$131.27K	—	—	—	—	—
Total Equity (USD)	$-2.71M	$-2.00M	$2.09M	$2.60M	$3.11M	$3.38M	$-920.41K	$-920.41K	$-265.77K

📋 What is driving earnings? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	$420.00	$740.00	$1.59K	$1.47K	—	—	—
Net Income, GAAP (USD)	$-2.01M	$-2.01M	$-4.06M	$-1.02M	$-538.77K	$-538.77K	$-862.79K	$-156.16K	—
Operating Cash Flow (USD)	$-463.07K	$-550.79K	$-1.06M	$-180.77K	$-209.33K	$-241.77K	—	$-15.00	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 3 years · 9 quarters

Caring Brands, Inc.

Analytical Summary

9-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CABR with peers